Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Joseph Medical Center
2323
mi
from 98109
Towson, MD
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Joseph Medical Center
2323
mi
from 98109
Towson, MD
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Boston Medical Center East
2485
mi
from 98109
Boston, MA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Boston Medical Center East
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Lahey Clinic
2474
mi
from 98109
Burlington, MA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Lahey Clinic
2474
mi
from 98109
Burlington, MA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Baystate Medical Center
2423
mi
from 98109
Springfield, MA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Baystate Medical Center
2423
mi
from 98109
Springfield, MA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
UMASS Memorial Medical Center
2454
mi
from 98109
Worcester, MA
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
UMASS Memorial Medical Center
2454
mi
from 98109
Worcester, MA
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Oakwood Hospital and Medical Center
1931
mi
from 98109
Dearborn, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Oakwood Hospital and Medical Center
1931
mi
from 98109
Dearborn, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St John Hospital & Medical Center
1937
mi
from 98109
Detroit, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St John Hospital & Medical Center
1937
mi
from 98109
Detroit, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Sparrow Hospital
1864
mi
from 98109
Lansing, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Sparrow Hospital
1864
mi
from 98109
Lansing, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Northern Michigan Hospital
1768
mi
from 98109
Petoskey, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Northern Michigan Hospital
1768
mi
from 98109
Petoskey, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St Joseph Mercy Oakland Hospital
1913
mi
from 98109
Pontiac, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St Joseph Mercy Oakland Hospital
1913
mi
from 98109
Pontiac, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
William Beaumont Hospital
1921
mi
from 98109
Royal Oak, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
William Beaumont Hospital
1921
mi
from 98109
Royal Oak, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Michigan Cardio Vascular Institute at St. Mary's of MI
1861
mi
from 98109
Saginaw, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Michigan Cardio Vascular Institute at St. Mary's of MI
1861
mi
from 98109
Saginaw, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Covenant Medical Center
1860
mi
from 98109
Saginaw, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Covenant Medical Center
1860
mi
from 98109
Saginaw, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Lakeland Hospital at St. Joseph
1780
mi
from 98109
St. Joseph, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Lakeland Hospital at St. Joseph
1780
mi
from 98109
St. Joseph, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St Joseph Mercy Hospital
1909
mi
from 98109
Ypsilanti, MI
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St Joseph Mercy Hospital
1909
mi
from 98109
Ypsilanti, MI
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
North Memorial Medical Center
1387
mi
from 98109
Minneapolis, MN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
North Memorial Medical Center
1387
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Mercy Hospital
1382
mi
from 98109
Minneapolis, MN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Mercy Hospital
1382
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Paul Heart Clinic
1399
mi
from 98109
St. Paul, MN
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Paul Heart Clinic
1399
mi
from 98109
St. Paul, MN
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Southern Heart Center
2070
mi
from 98109
Hattiesburg, MS
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Southern Heart Center
2070
mi
from 98109
Hattiesburg, MS
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Jackson Heart Clinic
1984
mi
from 98109
Jackson, MS
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Jackson Heart Clinic
1984
mi
from 98109
Jackson, MS
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
ST. Luke's Hospital
1504
mi
from 98109
Kansas City, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
ST. Luke's Hospital
1504
mi
from 98109
Kansas City, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
North Kansas City Hospital
1503
mi
from 98109
North Kansas City, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
North Kansas City Hospital
1503
mi
from 98109
North Kansas City, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. John's Research Institute, Inc., St. John's Hospital
1705
mi
from 98109
Springfield, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. John's Research Institute, Inc., St. John's Hospital
1705
mi
from 98109
Springfield, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Barnes Jewish Hospital
1718
mi
from 98109
St. Louis, MO
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Barnes Jewish Hospital
1718
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Billings Clinic Research Center
666
mi
from 98109
Billings, MT
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Billings Clinic Research Center
666
mi
from 98109
Billings, MT
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Dartmouth-Hitchock Medical Center
2390
mi
from 98109
Lebanon, NH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Dartmouth-Hitchock Medical Center
2390
mi
from 98109
Lebanon, NH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Englewood Hospital and Medical Center
2397
mi
from 98109
Englewood, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Englewood Hospital and Medical Center
2397
mi
from 98109
Englewood, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Hackensack Medical Center
2394
mi
from 98109
Hackensack, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Hackensack Medical Center
2394
mi
from 98109
Hackensack, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
CADV
2380
mi
from 98109
Haddon Heights, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
CADV
2380
mi
from 98109
Haddon Heights, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Joseph's Regional Medical Center
2387
mi
from 98109
Paterson, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Joseph's Regional Medical Center
2387
mi
from 98109
Paterson, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
The Valley Hospital
2388
mi
from 98109
Ridgewood, NJ
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
The Valley Hospital
2388
mi
from 98109
Ridgewood, NJ
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Peter's Hospital
2353
mi
from 98109
Albany, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Peter's Hospital
2353
mi
from 98109
Albany, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Jack D. Weiler Hospital of Montefiore Medical Center
2405
mi
from 98109
Bronx, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Jack D. Weiler Hospital of Montefiore Medical Center
2405
mi
from 98109
Bronx, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Buffalo Heart Group, LLC
2112
mi
from 98109
Buffalo, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Buffalo Heart Group, LLC
2112
mi
from 98109
Buffalo, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Mount Sinai Medical Center
2402
mi
from 98109
NY, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Mount Sinai Medical Center
2402
mi
from 98109
NY, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Rochester Cardiopulmonary Group
2161
mi
from 98109
Rochester, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Rochester Cardiopulmonary Group
2161
mi
from 98109
Rochester, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Stony Brook Hospital and Medical Center
2436
mi
from 98109
Stony Brook, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Stony Brook Hospital and Medical Center
2436
mi
from 98109
Stony Brook, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
St. Joseph's Hospital Health Center
2232
mi
from 98109
Syracuse, NY
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
St. Joseph's Hospital Health Center
2232
mi
from 98109
Syracuse, NY
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Univ of North Carolina
2337
mi
from 98109
Chapel Hill, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Univ of North Carolina
2337
mi
from 98109
Chapel Hill, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Carolinas Medical Center
2281
mi
from 98109
Charlotte, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Carolinas Medical Center
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Mid Carolina Cardiology
2281
mi
from 98109
Charlotte, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Mid Carolina Cardiology
2281
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Duke Univ Med Ctr
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Gaston Memorial Hospital
2265
mi
from 98109
Gastonia, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Gaston Memorial Hospital
2265
mi
from 98109
Gastonia, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
High Point Regional Health System
2292
mi
from 98109
High Point, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
High Point Regional Health System
2292
mi
from 98109
High Point, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
WakeMed Hospital
2362
mi
from 98109
Raleigh, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
WakeMed Hospital
2362
mi
from 98109
Raleigh, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Forsyth Medical Center
2273
mi
from 98109
Winston-Salem, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Forsyth Medical Center
2273
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Wake Forest University Baptist Medical Center
2275
mi
from 98109
Winston-Salem, NC
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Wake Forest University Baptist Medical Center
2275
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
Altru Health System
1168
mi
from 98109
Grand Forks, ND
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
Altru Health System
1168
mi
from 98109
Grand Forks, ND
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
The Christ Hospital
1966
mi
from 98109
Cincinnati, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
The Christ Hospital
1966
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated:  5/12/2016
University of Cincinnati Medical Center
1963
mi
from 98109
Cincinnati, OH
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)
Status: Enrolling
Updated: 5/12/2016
University of Cincinnati Medical Center
1963
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials